Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,308 papers from all fields of science
Search
Sign In
Create Free Account
Pseudoglucagonoma Syndrome
Known as:
Pseudoglucagonoma Syndromes
, Syndrome, Pseudoglucagonoma
, Syndromes, Pseudoglucagonoma
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Necrolytic Migratory Erythema
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
SUN-323 Somatostatin Analogue: An Effective Treatment for Pseudoglucagonoma Syndrome
Franco Vallejo Garcia
,
Valentina Rodríguez
Journal of the Endocrine Society
2019
Corpus ID: 164647761
Abstract INTRODUCTION: Pseudoglucagonoma syndrome (PS) refers to the presence of necrolytic migratory erythema (NME), despite…
Expand
Review
2019
Review
2019
Pseudoglucagonoma syndrome secondary to chronic pancreatitis: report of a case and review of the literature
Y. Mallick
,
N. Yaqoob
,
S. Rahim
2019
Corpus ID: 202799155
Necrolytic migratory erythema is a pathognomonic cutaneous presentation associated with glucagonoma and pseudoglucagonoma…
Expand
2016
2016
Necrolytic migratory erythema associated with fatty liver disease and the psuedoglucagonoma syndrome.
C. Fuller
,
Jaimie B. Glick
,
Shelly Rivas
,
Katy Burris
Dermatology Online Journal
2016
Corpus ID: 2224355
We report a 48-year-old woman with a past medical history of psoriasis, nonalcoholic steatohepatitis (NASH), and type II diabetes…
Expand
2013
2013
Necrolytic migratory erythema associated to pseudoglucagonoma syndrome
za María Ivonne Arellano Mendoza
,
ez Valerie Alcántara Ramírez
,
J. Aviña
,
Patricia Mercadillo Pérez
,
go Benito Vargas Ábrego
2013
Corpus ID: 73830857
2011
2011
Cirrhosis‐induced pseudoglucagonoma syndrome in a patient with Type 2 Diabetes: an autopsy study
Z. Ahmad
,
Savitha Shastry
,
F. Vuitch
,
A. Garg
Clinical Endocrinology
2011
Corpus ID: 205286222
dosages of antithyroid drugs, as it was the case in our patient (methimazole 80 mg daily; usual maintenance dose: 5–20 mg) as…
Expand
1997
1997
A Case of pseudoglucagonoma Syndrome Treated with Medium-chain Triglyceride
K. Seo
,
J. Park
,
H. Jang
,
K. Kwon
,
T. Chung
1997
Corpus ID: 78307331
1995
1995
[Pseudoglucagonoma syndrome. Case report, therapeutic possibilities and hypotheses on the etiology].
B. Ossowski
,
C. Baum
Der Hautarzt; Zeitschrift fur Dermatologie…
1995
Corpus ID: 30179242
We report on a 76-year-old female patient with clinical findings consistent with necrolytic migratory erythema. Plasma glucagon…
Expand
1995
1995
Das Pseudoglukagonom-Syndrom
B. Ossowski
,
C. Baum
Der Hautarzt
1995
Corpus ID: 41637738
Zusammenfassung. Wir berichten über eine 76jährige Patientin mit einem nekrolytischen migratorischen Erythem. Der Glukagonspiegel…
Expand
1988
1988
Necrolytic migratory erythema associated with odontogenic infection: an example of pseudoglucagonoma syndrome
M. Massa
,
R. Carlson
1988
Corpus ID: 56650998
1979
1979
Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis—possible pseudoglucagonoma syndrome *
J. Doyle
,
A. Schroeter
,
R. Rogers
British Journal of Dermatology
1979
Corpus ID: 26383790
Necrolytic migratory erythema is the distinctive cutaneous eruption seen with glucagon‐producing tumours of the pancreas…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE